Associate Director, Risk Quality Management, Oncology

Sumitomo Pharma Co., Ltd., is a global pharmaceutical company based in Japan with operations in the U.S. (Sumitomo Pharma America, Inc.), focused on addressing patient needs in oncology, urology, women's health, rare diseases, cell & gene therapies and CNS. With several marketed products and a diverse pipeline of early- to late-stage investigational assets, we aim to accelerate discovery, research, and development to bring novel therapies to patients sooner.

For more information on SMPA, visit our website  or follow us on Linked In.

The Associate Director, RBQM, provides study-level leadership for risk-based quality management across Phase 1–4 oncology clinical trials. Reporting to the Executive Director, Data Management, this role drives data-driven quality oversight, ensuring clinical trial risks are proactively identified, monitored, and mitigated in alignment with regulatory expectations and Sumitomo Pharma America quality standards.

• Plays a key role in facilitating understanding of the SMPA RBQM Strategy within Clinical Project Teams by providing targeted training sessions and ensuring alignment across team members.
• Lead and facilitate cross-functional risk assessment meetings.
• Maintain comprehensive and traceable documentation of all risk assessment activities, mitigation decisions, and quality parameters, ensuring periodic review and updates as required.
• Own the development, maintenance, and ongoing updates of Risk Assessment Categorization Tools (RACT) and Quality Risk Management Plans (QRMP) for assigned studies.
• Ensure alignment of functional study plans with approved risk assessment and quality parameter documents.
• Ensure alignment of study risks with Critical to Quality (CtQ) factors, protocol requirements, and data quality objectives.
• Partner closely with Data Management and Biostatistics to define, implement, and monitor KRIs and QTLs.
• Partner closely with Director Clinical Operations, Oncology, including RBQM central monitoring as part of the overall monitoring strategy.
• Lead the execution of centralized monitoring strategies, including ongoing data review, signal detection, and trend analysis.
• Provide expert guidance on targeted SDV and targeted SDR approaches based on evolving risk profiles.
• Interpret complex clinical and operational datasets to identify emerging risks and recommend mitigation strategies.
• Develop and deliver risk analytics, dashboards, and trend presentations to Clinical Project Teams and functional leadership.
• Act as the RBQM subject matter expert within Data Management, providing consultation and guidance to cross-functional stakeholders.
• Support inspection readiness by ensuring RBQM rationale, documentation, and decisions are inspection-ready and defensible.
• Contribute to the continuous improvement of RBQM processes, tools, and standards across Data Management.
• Maintain high proficiency in systems and technology as applicable to RBQM monitoring analytics and data access.
• Contribute to the SMPA technology strategy, including serving as business lead for specific technology.
• Ensure all risk assessment and quality management activities are conducted in accordance with related company SOPs, including documentation, approval, and filing requirements.
• Manage direct line reports, providing guidance, mentorship, and performance feedback to ensure their professional growth and the successful execution of their responsibilities.

• Bachelor's or advanced degree, preferably in life sciences, data analytics/ technology, or a related field.
• 8+ years of progressive experience in clinical development, data management, clinical quality, or RBQM.
• Demonstrated experience supporting or leading oncology clinical trials across Phase 1–4.
• Hands‑on experience with Trans Celerate RBQM frameworks, including RACT and QRMP ownership.
• Proven ability to lead risk assessments and influence cross‑functional teams without direct authority.
• Experience implementing centralized monitoring, KRIs, QTLs, and risk‑based SDV/SDR strategies.
• Experience operating effectively in a matrixed, global environment.
• Experience supporting regulatory inspections or audits…